| 63187-368-23 |
63187-368 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20160901 |
N/A |
ANDA |
ANDA091077 |
Proficient Rx LP |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (63187-368-23) |
| 50090-5310-0 |
50090-5310 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20201028 |
N/A |
ANDA |
ANDA091077 |
A-S Medication Solutions |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (50090-5310-0) |
| 68001-505-55 |
68001-505 |
HUMAN OTC DRUG |
Polyethylene Glycol |
Polyethylene Glycol |
POWDER, FOR SUSPENSION |
ORAL |
20210618 |
N/A |
ANDA |
ANDA091077 |
BluePoint Laboratories |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (68001-505-55) |
| 68001-505-69 |
68001-505 |
HUMAN OTC DRUG |
Polyethylene Glycol |
Polyethylene Glycol |
POWDER, FOR SUSPENSION |
ORAL |
20210618 |
N/A |
ANDA |
ANDA091077 |
BluePoint Laboratories |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
510 g in 1 BOTTLE (68001-505-69) |
| 17856-0312-1 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
17 g in 1 BAG (17856-0312-1) |
| 17856-0312-2 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
8.5 g in 1 BAG (17856-0312-2) |
| 17856-0312-3 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
17 g in 1 CUP (17856-0312-3) |
| 17856-0312-4 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
4 g in 1 BAG (17856-0312-4) |
| 17856-0312-5 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
50 CUP in 1 CASE (17856-0312-5) / 8.5 g in 1 CUP |
| 17856-0312-6 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20210126 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
72 POUCH in 1 CASE (17856-0312-6) / 4.5 g in 1 POUCH |
| 17856-0312-7 |
17856-0312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20231010 |
N/A |
ANDA |
ANDA091077 |
ATLANTIC BIOLOGICALS CORP. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
50 BAG in 1 BOX, UNIT-DOSE (17856-0312-7) / 4.25 g in 1 BAG (17856-0312-8) |
| 43386-312-08 |
43386-312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20091009 |
N/A |
ANDA |
ANDA091077 |
Lupin Pharmaceuticals,Inc. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (43386-312-08) |
| 43386-312-14 |
43386-312 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20091009 |
N/A |
ANDA |
ANDA091077 |
Lupin Pharmaceuticals,Inc. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
510 g in 1 BOTTLE (43386-312-14) |
| 68788-7508-2 |
68788-7508 |
HUMAN OTC DRUG |
GAVILAX |
Polyethylene Glycol 3350 |
POWDER, FOR SOLUTION |
ORAL |
20191028 |
N/A |
ANDA |
ANDA091077 |
Preferred Pharmaceuticals, Inc. |
POLYETHYLENE GLYCOL 3350 |
17 g/17g |
238 g in 1 BOTTLE (68788-7508-2) |